Home » Authors » Nuala Moran

Articles by Nuala Moran

GlaxoSmithKline Adopts Biotech Business Model, Creates Six Units

Feb. 28, 2001

Xenova On Track To Partner XR9576 Following Phase II

Feb. 28, 2001

MVM Raising £40M To Invest In Young U.S., UK Companies

Feb. 28, 2001

Xenova, Cantab Merging Via All-Stock Deal Valued At £124

Feb. 21, 2001

Cyclacel Moves Oral CDK Inhibitor Into Human Trials

Feb. 21, 2001

Pharming Completes Study, Enters Deal With AM-Pharma

Feb. 21, 2001

Cyclacel Moves Oral CDK Inhibitor Into Human Trials

Feb. 21, 2001

Xenova, Cantab Merging Via All-Stock Deal Valued At £124

Feb. 21, 2001

Pharming Completes Study, Enters Deal With AM-Pharma

Feb. 21, 2001

HUPO Formed To Capitalize On Genome, Advance Proteomics

Feb. 20, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.